Veeda Group Rebrands as Veeda Lifesciences

In a major step forward, Veeda Group, a trusted name in Contract Research, has rebranded itself as Veeda Lifesciences, reflecting its evolution into a dynamic, full-spectrum partner in drug development. This transformation is not just about a new name or logo—it’s about a renewed commitment to making a meaningful impact in the lives of patients and healthcare innovators worldwide.

Why the Change?

For nearly two decades, Veeda has been known for its expertise in supporting generics research. But as the needs of the life sciences industry have grown, so has Veeda. Today, the company offers cutting-edge services across drug development, from generics to novel chemical and biological entities. The new identity, Veeda Lifesciences, reflects this broader vision—a vision rooted in innovation, excellence, and a deep focus on meeting client needs.

Dr. Mahesh Bhalgat, Group CEO and Managing Director, shares the heart behind the change:
"The name Veeda Lifesciences and the new logo capture our forward-thinking approach. They symbolize our growth, aspirations, and unwavering dedication to supporting our clients and their mission to improve healthcare outcomes. It’s about stepping into the future with confidence while staying true to our values."

What’s New?

Veeda Lifesciences is organized into four specialized areas of focus, ensuring a seamless journey for clients through every stage of drug development:

1. Clinical Trials: From Europe to India, Veeda manages studies that prioritize patient care and robust data.
2. Healthy Volunteer Services: Advanced clinical bioanalysis in Gujarat supports the development of small molecules.
3. Biopharma Services: Based in Bengaluru, this unit focuses on biologics, offering everything from analytical characterization to process development.
4. Preclinical & Non-Clinical Testing Services: Located in Karnataka, this division handles the critical early-stage research that lays the foundation for success.

A Journey from Local to Global

Veeda began its journey in India in 2004, but its vision has always been global. Today, the company operates in five countries and conducts trials across 26 geographies. Strategic partnerships, like the acquisition of Bioneeds India in 2021, have allowed Veeda to expand its expertise and capabilities, helping clients navigate the complex world of drug discovery and development.

A Commitment to Innovation

Veeda isn’t just growing—it’s innovating. By adopting a hybrid CRO-CDMO model and embracing technologies like AI and real-world data, Veeda Lifesciences is empowering its clients to make faster, smarter decisions.

A Future Built on Trust

For Veeda Lifesciences, this rebrand is not just about what the company does—it’s about why it does it. By combining expertise with empathy, Veeda remains steadfast in its mission to support the discovery of treatments and therapies that change lives.

As Veeda Lifesciences embarks on this exciting new chapter, it does so with gratitude for its journey so far and optimism for the road ahead. With a renewed sense of purpose and a clear vision for the future, the company is ready to partner with clients, researchers, and healthcare innovators around the world to deliver what truly matters: better health outcomes for all.

"This isn’t just about expanding our capabilities; it’s about making a difference," Dr. Bhalgat emphasizes. "Our new identity is a promise—to ourselves, to our clients, and to the patients who depend on us—that we’ll keep striving for innovation, excellence, and the trust that defines Veeda."